Enter inventor name

Eric E Jarvis

USPTO Granted Patents = 28 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 2,483(Granted Patents)

Company Filing History:

14 out of 160

Sangamo Biosciences, Inc.

patents

5 out of 509

Alliance for Sustainable Energy, LLC

patents

2 out of 278

Midwest Research Institute

6. 3 out of 832,843

Other

patents

Years Active: 1995-2018

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10036051 - Enhanced processive cellulases (2018-07-31),

2. 9683248 - Enhanced processive cellulases (2017-06-20),

3. 9491934 - Regulation of endogenous gene expression in cells using zinc finger proteins (2016-11-15),

4. 9207018 - Sub-wet bulb evaporative chiller system with multiple integrated subunits or chillers (2015-12-08),

5. 8841090 - L-arabinose fermenting yeast (2014-09-23),

6. 8372626 - L-arabinose fermenting yeast (2013-02-12),

7. 8268618 - Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins (2012-09-18),

8. 8071564 - Regulation of angiogenesis with zinc finger proteins (2011-12-06),

9. 7985887 - Regulation of endogenous gene expression in cells using zinc finger proteins (2011-07-26),

10. 7846712 - L-arabinose fermenting yeast (2010-12-07),

11. 7698906 - Sub-wet bulb evaporative chiller with pre-cooling of incoming air flow (2010-04-20),

12. 7667019 - Flea ultraspiracle nucleic acid molecules (2010-02-23),

13. 7605140 - Regulation of angiogenesis with zinc finger proteins (2009-10-20),

14. 7560440 - Regulation of angiogenesis with zinc finger proteins (2009-07-14),

15. 7208589 - Flea ultraspiracle nucleic acid molecules and uses thereof (2007-04-24),

Title: The Innovative Contributions of Eric E. Jarvis in Biotechnology

Introduction

Eric E. Jarvis is a renowned inventor based in Boulder, Colorado, with an impressive portfolio of 28 patents to his name. His work predominantly focuses on biotechnological innovations, particularly in the realm of cellulases, which have significant applications in the degradation of cellulosic materials.

Latest Patents

Among Eric Jarvis's latest patents is a groundbreaking invention involving enhanced processive cellulases. This patent discloses nucleic acid sequences that encode chimeric polypeptides exhibiting enhanced cellulase activities. These nucleic acids can be expressed in hosts such as fungi, which can then be cultured to produce these chimeric polypeptides. The versatility of these chimeric polypeptides paves the way for their use in the efficient degradation of cellulosic materials, marking a significant advancement in the field.

Career Highlights

Throughout his career, Eric has made substantial contributions to various organizations. He has worked with Sangamo Biosciences, Inc., and the Alliance for Sustainable Energy, LLC. His innovations in biotechnology have not only advanced scientific knowledge but also fostered developments in sustainable energy solutions.

Collaborations

Collaboration stands as a cornerstone of Eric’s professional journey. Notable collaborators include Stephen P. Eisenberg and Casey Christopher Case, with whom he has shared insights and expertise to further advance their field. Their combined efforts have helped to drive innovation in the biotechnological domain, reflecting a commitment to collaborative research and development.

Conclusion

Eric E. Jarvis has carved a niche for himself in the biotechnology sector through his inventive spirit and dedicated research. His 28 patents, particularly in the field of enhanced processive cellulases, showcase his significant contributions to biotechnological applications and sustainable practices. As the industry evolves, his innovations will undoubtedly continue to influence future advancements in the degradation of cellulosic materials and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com